Published • loading... • Updated
Kaneka Intends to Appeal Invalidity Decision in Lawsuit Against CoCrystal
- Kaneka Corporation sued CoCrystal in the U.S. District Court for the Eastern District of New York, alleging infringement of its U.S. Patent No. 7,829,080 related to reduced coenzyme Q10 supplements.
- On September 2, 2026, the New York District Court dismissed Kaneka's lawsuit, ruling the patent invalid for lack of enablement.
- Kaneka disagrees with the court's decision, citing prior tests showing significant utility and earlier validation of the patent by another court.
- Kaneka plans to appeal the dismissal to the Federal Circuit Court of Appeals and remains committed to defending its intellectual property rights.
Insights by Ground AI
36 Articles
36 Articles
Kaneka intends to appeal the annulment decision in the CoCrystal trial
·Buenos Aires, Argentina
Read Full Article
The Courier-Tribune+34 Reposted by 34 other sources
Kaneka Intends to Appeal Invalidity Decision in Lawsuit Against CoCrystal
TOKYO, Sept. 8, 2026 /PRNewswire/ -- On October 5, 2023, Kaneka Corporation filed a complaint against Cocrystal Technology (Jiaxing) Co., Ltd. and Cocrystal Health Industry (Zhejiang) Co., Ltd. (collectively "CoCrystal") in the U.S. District Court for the Eastern District of…
Coverage Details
Total News Sources36
Leaning Left7Leaning Right3Center22Last UpdatedBias Distribution69% Center
Bias Distribution
- 69% of the sources are Center
69% Center
L 22%
C 69%
Factuality
To view factuality data please Upgrade to Premium
